A Phase I/II Pilot Study Of Sequential Vaccinations With rFowlpox-PSA (L155)-Tricom (PROSTVAC-F/TRICOM) Alone, Or In Combination With rVaccinia-PSA(L155)-TRICOM (PROSTVAC-V/TRICOM), And The Role Of GM-CSF, In Men With Prostate Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Rilimogene galvacirepvec (Primary) ; Rilimogene glafolivec (Primary) ; Granulocyte-macrophage colony-stimulating factors
- Indications Prostate cancer
- Focus Therapeutic Use
- 26 Oct 2017 Biomarkers information updated
- 22 Feb 2012 Actual patient number changed from 47 to 32 as reported by ClinicalTrials.gov.
- 22 Feb 2012 Actual patient number changed from 47 to 32 as reported by ClinicalTrials.gov.